Maria G Pascucci

Recommended Articles

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

• What Test Determines Lactose Intolerance?

  ...

• Appendicitis: Get the Facts

  Appendicitis is an acute or chronic condition which causes inflammation of the appendix. According to the National Institute of Diabetes and Digestive and Kidney Diseases, it is the most common cause of abdominal pain in the US which results in surgery. It has also been found that about 5% of the...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...

• Trazodone: Withdrawal, Abuse, and Overdose

  Trazodone AbuseTrazodone is an antidepressant drug which is prescribed to treat and manage major depressive disorder. Depression is a mental disorder which causes extreme feelings of sadness and loss of interest in activities and life.Trazodone must be taken with care because its effect on the...

• Heartburn: What to Eat and What Not to Eat

  Heartburn is the burning sensation of the chest, which often feels like chest pain. This is one of the classic symptoms of acid reflux, and it is a result of acid into the esophagus. Acid reflux is the escape of acidic contents of the stomach through the lower esophageal sphincter to the...